{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T23:13:06Z","timestamp":1763766786566,"version":"build-2065373602"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T00:00:00Z","timestamp":1570665600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"COHEAHR Network"},{"DOI":"10.13039\/100013017","name":"VU University Medical Center","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100013017","id-type":"DOI","asserted-by":"crossref"}]},{"name":"7th Framework Programme of the European Commission"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.jcv.2019.104201","type":"journal-article","created":{"date-parts":[[2019,10,12]],"date-time":"2019-10-12T10:47:33Z","timestamp":1570877253000},"page":"104201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Clinical performance of the HPV-Risk assay on cervical samples in SurePath medium using the VALGENT-4 panel"],"prefix":"10.1016","volume":"121","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6463-7391","authenticated-orcid":false,"given":"D.A.M.","family":"Heideman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.T.","family":"Hesselink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Doorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.M.","family":"Ejegod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.G.V.","family":"Quint","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4853-6747","authenticated-orcid":false,"given":"J.","family":"Bonde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Arbyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 5","key":"10.1016\/j.jcv.2019.104201_bib0005","doi-asserted-by":"crossref","first-page":"F88","DOI":"10.1016\/j.vaccine.2012.06.095","article-title":"Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer","volume":"30","author":"Arbyn","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2019.104201_bib0010","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.pvr.2015.06.006","article-title":"European guidelines for quality assurance in cervical cancer screening. Summary of the supplements on HPV screening and vaccination","volume":"1","author":"von Karsa","year":"2015","journal-title":"Papillomavirus Res."},{"key":"10.1016\/j.jcv.2019.104201_bib0015","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/ijc.24010","article-title":"Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older","volume":"124","author":"Meijer","year":"2009","journal-title":"Int. J. Cancer"},{"issue":"Suppl 3","key":"10.1016\/j.jcv.2019.104201_bib0020","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1386-6532(09)00540-X","article-title":"Validation of high-risk HPV tests for primary cervical screening","volume":"46","author":"Meijer","year":"2009","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jcv.2019.104201_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/path.1433","article-title":"The clinical relevance of human papillomavirus testing\u202f: relationship between analytical and clinical sensitivity","volume":"201","author":"Snijders","year":"2003","journal-title":"J. Pathol."},{"key":"10.1016\/j.jcv.2019.104201_bib0030","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jcv.2018.09.012","article-title":"The Valgent4 protocol: robust analytical and clinical validation of 11 HPV assays with genotyping on cervical samples collected in SurePath medium","volume":"108","author":"Bonde","year":"2018","journal-title":"J. Clin. Virol."},{"issue":"Suppl 1","key":"10.1016\/j.jcv.2019.104201_bib0035","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.jcv.2015.09.014","article-title":"VALGENT: a protocol for clinical validation of human papillomavirus assays","volume":"76","author":"Arbyn","year":"2016","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jcv.2019.104201_bib0040","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1128\/JCM.03195-13","article-title":"Clinical validation of the HPV-risk assay, a novel real-time PCR assay for detection of high-risk human papillomavirus DNA by targeting the E7 region","volume":"52","author":"Hesselink","year":"2014","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jcv.2019.104201_bib0045","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1128\/JCM.01282-17","article-title":"Evaluation of the clinical performance of the HPV-Risk assay using the VALGENT-3 panel","volume":"55","author":"Polman","year":"2017","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jcv.2019.104201_bib0050","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.1128\/JCM.01962-14","article-title":"Clinical evaluation of a GP5+\/6+-based luminex assay having full high-risk human papillomavirus genotyping capability and an internal control","volume":"52","author":"Geraets","year":"2014","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jcv.2019.104201_bib0055","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1002\/sim.1213","article-title":"On tests of equivalence via non-unity relative risk for matched-pair design","volume":"22","author":"Tang","year":"2003","journal-title":"Stat. Med."},{"key":"10.1016\/j.jcv.2019.104201_bib0060","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1038\/s41598-019-39275-2","article-title":"Cervical cancer detection by DNA methylation analysis in urine","volume":"9","author":"Snoek","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jcv.2019.104201_bib0065","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.cmi.2015.04.015","article-title":"Which high-risk HPV assays fulfill criteria for use in primary cervical cancer screening?","volume":"21","author":"Arbyn","year":"2015","journal-title":"Clin. Microbiol. Infect."}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653219302197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653219302197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T03:11:21Z","timestamp":1761361881000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653219302197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":13,"alternative-id":["S1386653219302197"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2019.104201","relation":{},"ISSN":["1386-6532"],"issn-type":[{"type":"print","value":"1386-6532"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical performance of the HPV-Risk assay on cervical samples in SurePath medium using the VALGENT-4 panel","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2019.104201","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104201"}}